<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37730668</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges.</ArticleTitle><Pagination><StartPage>46</StartPage><MedlinePgn>46</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">46</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-023-00377-7</ELocationID><Abstract><AbstractText>In order to dissect amyotrophic lateral sclerosis (ALS), a multigenic, multifactorial, and progressive neurodegenerative disease with heterogeneous clinical presentations, researchers have generated numerous animal models to mimic the genetic defects. Concurrent and comparative analysis of these various models allows identification of the causes and mechanisms of ALS in order to finally obtain effective therapeutics. However, most genetically modified rodent models lack overt pathological features, imposing challenges and limitations in utilizing them to rigorously test the potential mechanisms. Recent studies using large animals, including pigs and non-human primates, have uncovered important events that resemble neurodegeneration in patients' brains but could not be produced in small animals. Here we describe common features as well as discrepancies among these models, highlighting new insights from these models. Furthermore, we will discuss how to make rodent models more capable of recapitulating important pathological features based on the important pathogenic insights from large animal models.</AbstractText><CopyrightInformation>&#xa9; 2023. Ruijin Hospital, Shanghai Jiao Tong University.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Longhong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Non-Human Primate Research, Key Laboratory of CNS Regeneration (Ministry of Education), GHM Institute of CNS Regeneration, Jinan University, Guangzhou, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shihua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Non-Human Primate Research, Key Laboratory of CNS Regeneration (Ministry of Education), GHM Institute of CNS Regeneration, Jinan University, Guangzhou, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao-Jiang</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Non-Human Primate Research, Key Laboratory of CNS Regeneration (Ministry of Education), GHM Institute of CNS Regeneration, Jinan University, Guangzhou, 510632, China. xjli33@jnu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Non-Human Primate Research, Key Laboratory of CNS Regeneration (Ministry of Education), GHM Institute of CNS Regeneration, Jinan University, Guangzhou, 510632, China. yinpeng177@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Animal model</Keyword><Keyword MajorTopicYN="N">Non-human primate</Keyword><Keyword MajorTopicYN="N">Rodent</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37730668</ArticleId><ArticleId IdType="pmc">PMC10510301</ArticleId><ArticleId IdType="doi">10.1186/s40035-023-00377-7</ArticleId><ArticleId IdType="pii">10.1186/s40035-023-00377-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. ALS. 2009;10(5&#x2013;6):310&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A, Al-Chalabi A. The genetic architecture of ALS. Neurobiol Dis. 2021;147:105156. doi: 10.1016/j.nbd.2020.105156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105156</ArticleId><ArticleId IdType="pubmed">33130222</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, Lehmann M, Beaudin M, Nordstr&#xf6;m U, Saikali S, Julien J-P, et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci Rep. 2018;8(1):14223. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet. 2013;92(3):345&#x2013;353. doi: 10.1016/j.ajhg.2013.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.01.011</ArticleId><ArticleId IdType="pmc">PMC3591848</ArticleId><ArticleId IdType="pubmed">23434116</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, et al. The C9ORF72 expansion mutation is a common cause of ALS+/&#x2212; FTD in Europe and has a single founder. Eur J Hum Genet. 2013;21(1):102&#x2013;108. doi: 10.1038/ejhg.2012.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2012.98</ArticleId><ArticleId IdType="pmc">PMC3522204</ArticleId><ArticleId IdType="pubmed">22692064</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard SR, Parker MD, Cooper-Knock J, Verber NS, Tuddenham L, Heath P, et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021;92(5):510&#x2013;518. doi: 10.1136/jnnp-2020-325014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325014</ArticleId><ArticleId IdType="pmc">PMC8053339</ArticleId><ArticleId IdType="pubmed">33589474</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T, Jr, Bosco D, Leclerc A, Tamrazian E, Vanderburg C, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323(5918):1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323(5918):1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z-Y, Zhou Z-R, Che C-H, Liu C-Y, He R-L, Huang H-P. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88(7):540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P, Li S, Li XJ, Yang W. New pathogenic insights from large animal models of neurodegenerative diseases. Protein Cell. 2022;13(10):707&#x2013;720. doi: 10.1007/s13238-022-00912-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-022-00912-8</ArticleId><ArticleId IdType="pmc">PMC9233730</ArticleId><ArticleId IdType="pubmed">35334073</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264(5166):1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Ando Y. Genotype&#x2013;phenotype relationship in hereditary amyotrophic lateral sclerosis. Transl Neurodegener. 2015;4:13. doi: 10.1186/s40035-015-0036-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-015-0036-y</ArticleId><ArticleId IdType="pmc">PMC4513711</ArticleId><ArticleId IdType="pubmed">26213621</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HF, Wu ZY. Genotype&#x2013;phenotype correlations of amyotrophic lateral sclerosis. Transl Neurodegener. 2016;5:3. doi: 10.1186/s40035-016-0050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-016-0050-8</ArticleId><ArticleId IdType="pmc">PMC4738789</ArticleId><ArticleId IdType="pubmed">26843957</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keranen ML, et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain. 1996;119(Pt 4):1153&#x2013;1172. doi: 10.1093/brain/119.4.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.4.1153</ArticleId><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, Homma K, Ichijo H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul. 2016;60:95&#x2013;104. doi: 10.1016/j.jbior.2015.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2015.10.006</ArticleId><ArticleId IdType="pubmed">26563614</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Igoudjil A, Magran&#xe9; J, Li Y, Hansen JM, Manfredi G, et al. SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse. Brain. 2011;134(1):196&#x2013;209. doi: 10.1093/brain/awq314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq314</ArticleId><ArticleId IdType="pmc">PMC3009841</ArticleId><ArticleId IdType="pubmed">21078595</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Li Y, Asress SA, Jones DP, Glass JD. Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy. Exp Neurol. 2012;233(1):163&#x2013;171. doi: 10.1016/j.expneurol.2011.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.09.020</ArticleId><ArticleId IdType="pmc">PMC4068963</ArticleId><ArticleId IdType="pubmed">21963651</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda P, Van Den Bosch L, Hirth F. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat Rev Neurosci. 2021;22(4):197&#x2013;208. doi: 10.1038/s41583-021-00431-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00431-1</ArticleId><ArticleId IdType="pubmed">33654312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet. 2017;136(9):1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 2010;7(4):420&#x2013;429. doi: 10.4161/rna.7.4.12205.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.7.4.12205</ArticleId><ArticleId IdType="pubmed">20639693</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J Neurochem. 2016;138(Suppl 1):95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2020;92(1):86&#x2013;95. doi: 10.1136/jnnp-2020-322983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322983</ArticleId><ArticleId IdType="pmc">PMC7803890</ArticleId><ArticleId IdType="pubmed">33177049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, Lee VM, et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010;119(4):409&#x2013;419. doi: 10.1007/s00401-010-0659-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0659-0</ArticleId><ArticleId IdType="pmc">PMC2880609</ArticleId><ArticleId IdType="pubmed">20198480</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H, Sok J, Immanuel D, Yin Y, Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci. 1997;110(Pt 15):1741&#x2013;1750. doi: 10.1242/jcs.110.15.1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.110.15.1741</ArticleId><ArticleId IdType="pubmed">9264461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Rouleau GA, Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat. 2013;34(6):812&#x2013;826. doi: 10.1002/humu.22319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22319</ArticleId><ArticleId IdType="pubmed">23559573</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Lyashchenko AK, Lu L, Nasrabady SE, Elmaleh M, Mendelsohn M, et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun. 2018;9(1):335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu S, Liu G, Ozturk A, Hicks GG. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013;9(10):e1003895. doi: 10.1371/journal.pgen.1003895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003895</ArticleId><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J, Birsa N, Milioto C, McLaughlin M, Ule AM, Robaldo D, et al. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 2020;48(12):6889&#x2013;6905. doi: 10.1093/nar/gkaa410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa410</ArticleId><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig S, Kong G, Mannen T, Sadowska A, Kobelke S, Blythe A, et al. Prion-like domains in RNA binding proteins are essential for building subnuclear paraspeckles. J Cell Biol. 2015;210(4):529&#x2013;539. doi: 10.1083/jcb.201504117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504117</ArticleId><ArticleId IdType="pmc">PMC4539981</ArticleId><ArticleId IdType="pubmed">26283796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang W, Hu F. Cellular and physiological functions of C9ORF72 and implications for ALS/FTD. J Neurochem. 2021;157(3):334&#x2013;350. doi: 10.1111/jnc.15255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15255</ArticleId><ArticleId IdType="pmc">PMC8842544</ArticleId><ArticleId IdType="pubmed">33259633</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D, Sheng J, Xu L, Zhan X, Liu J, Jiang H, et al. Cryo-EM structure of C9ORF72&#x2013;SMCR8&#x2013;WDR41 reveals the role as a GAP for Rab8a and Rab11a. Proc Natl Acad Sci USA. 2020;117(18):9876&#x2013;9883. doi: 10.1073/pnas.2002110117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2002110117</ArticleId><ArticleId IdType="pmc">PMC7211967</ArticleId><ArticleId IdType="pubmed">32303654</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M-Y, Fromm SA, Zoncu R, Hurley JH. Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD. Nature. 2020;585(7824):251&#x2013;255. doi: 10.1038/s41586-020-2633-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2633-x</ArticleId><ArticleId IdType="pmc">PMC8054479</ArticleId><ArticleId IdType="pubmed">32848248</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126(6):829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Belzil VV, Zhang YJ, Petrucelli L. Mechanisms of toxicity in C9FTLD/ALS. Acta Neuropathol. 2014;127(3):359&#x2013;376. doi: 10.1007/s00401-013-1237-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1237-z</ArticleId><ArticleId IdType="pmc">PMC4002260</ArticleId><ArticleId IdType="pubmed">24394885</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci USA. 2011;108(1):260&#x2013;265. doi: 10.1073/pnas.1013343108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1013343108</ArticleId><ArticleId IdType="pmc">PMC3017129</ArticleId><ArticleId IdType="pubmed">21173221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary JD, Ranum LP. New developments in RAN translation: insights from multiple diseases. Curr Opin Genet Dev. 2017;44:125&#x2013;134. doi: 10.1016/j.gde.2017.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.03.006</ArticleId><ArticleId IdType="pmc">PMC5951168</ArticleId><ArticleId IdType="pubmed">28365506</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, Baumer D, East S, Neal J, Morris HR, Ansorge O, et al. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging. 2014;35(7):e1775&#x2013;e1713. doi: 10.1016/j.neurobiolaging.2014.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond CS, Kaneb HM, Dion PA, Rouleau GA. Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp Neurol. 2014;262:91&#x2013;101. doi: 10.1016/j.expneurol.2014.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.04.013</ArticleId><ArticleId IdType="pubmed">24780888</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten SA, Parker JA, Wen XY, Drapeau P. Simple animal models for amyotrophic lateral sclerosis drug discovery. Expert Opin Drug Discov. 2016;11(8):797&#x2013;804. doi: 10.1080/17460441.2016.1196183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2016.1196183</ArticleId><ArticleId IdType="pubmed">27249162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Zhao Y, Chen Y, Cheng B, Peng A, Huang K. Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases. Eur J Pharmacol. 2018;819:169&#x2013;180. doi: 10.1016/j.ejphar.2017.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2017.11.051</ArticleId><ArticleId IdType="pubmed">29208474</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten SA, Armstrong GA, Lissouba A, Kabashi E, Parker JA, Drapeau P. Fishing for causes and cures of motor neuron disorders. Dis Model Mech. 2014;7(7):799&#x2013;809. doi: 10.1242/dmm.015719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.015719</ArticleId><ArticleId IdType="pmc">PMC4073270</ArticleId><ArticleId IdType="pubmed">24973750</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortier G, Butti Z, Patten SA. Modelling C9orf72-related amyotrophic lateral sclerosis in zebrafish. Biomedicines. 2020;8(10):440. doi: 10.3390/biomedicines8100440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8100440</ArticleId><ArticleId IdType="pmc">PMC7589578</ArticleId><ArticleId IdType="pubmed">33096681</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Farr GW, Hall DH, Li F, Furtak K, Dreier L, et al. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet. 2009;5(1):e1000350. doi: 10.1371/journal.pgen.1000350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000350</ArticleId><ArticleId IdType="pmc">PMC2621352</ArticleId><ArticleId IdType="pubmed">19165329</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskoylu SN, Yersak J, O'Hern P, Grosser S, Simon J, Kim S, et al. Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration. PLoS Genet. 2018;14(10):e1007682. doi: 10.1371/journal.pgen.1007682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007682</ArticleId><ArticleId IdType="pmc">PMC6200258</ArticleId><ArticleId IdType="pubmed">30296255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemmens R, Van Hoecke A, Hersmus N, Geelen V, D'Hollander I, Thijs V, et al. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum Mol Genet. 2007;16(19):2359&#x2013;2365. doi: 10.1093/hmg/ddm193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm193</ArticleId><ArticleId IdType="pubmed">17636250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh T, Lyon AN, Pineda RH, Wang C, Janssen PM, Canan BD, et al. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis Model Mech. 2010;3(9&#x2013;10):652&#x2013;662. doi: 10.1242/dmm.005538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.005538</ArticleId><ArticleId IdType="pmc">PMC2931540</ArticleId><ArticleId IdType="pubmed">20504969</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, Shadfar S, Perri ER, Ragagnin AMG, Piattoni CV, Fogolin MB, et al. The redox activity of protein disulfide isomerase inhibits ALS phenotypes in cellular and zebrafish models. iScience. 2020;23(5):101097. doi: 10.1016/j.isci.2020.101097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101097</ArticleId><ArticleId IdType="pmc">PMC7240177</ArticleId><ArticleId IdType="pubmed">32446203</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, Yang SP, Xie L, Kawano T, Fu D, Mukai A, et al. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism. Hum Mol Genet. 2012;21(1):1&#x2013;9. doi: 10.1093/hmg/ddr417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr417</ArticleId><ArticleId IdType="pmc">PMC3235006</ArticleId><ArticleId IdType="pubmed">21949354</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A, Tauffenberger A, Aggad D, Rouleau G, Drapeau P, Parker JA. Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans. PLoS ONE. 2012;7(2):e31321. doi: 10.1371/journal.pone.0031321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031321</ArticleId><ArticleId IdType="pmc">PMC3283630</ArticleId><ArticleId IdType="pubmed">22363618</ArticleId></ArticleIdList></Reference><Reference><Citation>Markert SM, Skoruppa M, Yu B, Mulcahy B, Zhen M, Gao S, et al. Overexpression of an ALS-associated FUS mutation in C. elegans disrupts NMJ morphology and leads to defective neuromuscular transmission. Biol Open. 2020;9(12):bio055129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746668</ArticleId><ArticleId IdType="pubmed">33148607</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GA, Drapeau P. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum Mol Genet. 2013;22(21):4282&#x2013;4292. doi: 10.1093/hmg/ddt278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt278</ArticleId><ArticleId IdType="pubmed">23771027</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GAB, Liao M, You Z, Lissouba A, Chen BE, Drapeau P. Homology directed knockin of point mutations in the zebrafish tardbp and fus genes in ALS using the CRISPR/Cas9 system. PLoS ONE. 2016;11(3):e0150188. doi: 10.1371/journal.pone.0150188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150188</ArticleId><ArticleId IdType="pmc">PMC4773037</ArticleId><ArticleId IdType="pubmed">26930076</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M-L, Bourefis A-R, Buee-Scherrer V, Kabashi E. Freezing activity brief data from a new FUS mutant zebrafish line. Data Brief. 2020;31:105921. doi: 10.1016/j.dib.2020.105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dib.2020.105921</ArticleId><ArticleId IdType="pmc">PMC7352050</ArticleId><ArticleId IdType="pubmed">32676526</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourefis A-R, Campanari M-L, Bu&#xe9;e-Scherrer V, Kabashi E. Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS. Neurobiol Dis. 2020;142:104935. doi: 10.1016/j.nbd.2020.104935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104935</ArticleId><ArticleId IdType="pubmed">32380281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Brustein E, Champagne N, Drapeau P. Zebrafish models for the functional genomics of neurogenetic disorders. Biochim Biophys Acta Mol Basis Dis. 2011;1812(3):335&#x2013;345. doi: 10.1016/j.bbadis.2010.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2010.09.011</ArticleId><ArticleId IdType="pubmed">20887784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, Zhang YJ, Roberts CM, Saldi T, Hutter H, Buratti E, et al. Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum Mol Genet. 2010;19(16):3206&#x2013;3218. doi: 10.1093/hmg/ddq230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq230</ArticleId><ArticleId IdType="pmc">PMC2908471</ArticleId><ArticleId IdType="pubmed">20530643</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, Guthrie CR, Kraemer BC. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci. 2010;30(48):16208&#x2013;16219. doi: 10.1523/JNEUROSCI.2911-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2911-10.2010</ArticleId><ArticleId IdType="pmc">PMC3075589</ArticleId><ArticleId IdType="pubmed">21123567</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A, Tauffenberger A, Ash PE, Carlomagno Y, Petrucelli L, Parker JA. TDP-1/TDP-43 regulates stress signaling and age-dependent proteotoxicity in Caenorhabditis elegans. PLoS Genet. 2012;8(7):e1002806. doi: 10.1371/journal.pgen.1002806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002806</ArticleId><ArticleId IdType="pmc">PMC3390363</ArticleId><ArticleId IdType="pubmed">22792076</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P, et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet. 2010;19(4):671&#x2013;683. doi: 10.1093/hmg/ddp534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp534</ArticleId><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M, Rouleau GA, Dion PA, Parker JA. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS ONE. 2013;8(12):e83450. doi: 10.1371/journal.pone.0083450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083450</ArticleId><ArticleId IdType="pmc">PMC3861484</ArticleId><ArticleId IdType="pubmed">24349511</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrionero A, Horvitz HR. A C9orf72 ALS/FTD ortholog acts in endolysosomal degradation and lysosomal homeostasis. Curr Biol. 2018;28(10):1522&#x2013;1535. doi: 10.1016/j.cub.2018.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.03.063</ArticleId><ArticleId IdType="pubmed">29731301</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Bento-Abreu A, Gendron TF, Boeynaems S, Bogaert E, Nuyts R, et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135(3):427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw MP, Higginbottom A, McGown A, Castelli LM, James E, Hautbergue GM, et al. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Acta Neuropathol Commun. 2018;6(1):125. doi: 10.1186/s40478-018-0629-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0629-7</ArticleId><ArticleId IdType="pmc">PMC6240957</ArticleId><ArticleId IdType="pubmed">30454072</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolus H, Crocker K, Boekhoff-Falk G, Chtarbanova S. Modeling neurodegenerative disorders in Drosophila melanogaster. Int J Mol Sci. 2020;21(9):3055. doi: 10.3390/ijms21093055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21093055</ArticleId><ArticleId IdType="pmc">PMC7246467</ArticleId><ArticleId IdType="pubmed">32357532</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, Amanatides PG, et al. The genome sequence of Drosophila melanogaster. Science. 2000;287(5461):2185&#x2013;2195. doi: 10.1126/science.287.5461.2185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.287.5461.2185</ArticleId><ArticleId IdType="pubmed">10731132</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y, Mizuta I, Tokuda T, Mizuno T. Amyotrophic lateral sclerosis model. Adv Exp Med Biol. 2018;1076:79&#x2013;95. doi: 10.1007/978-981-13-0529-0_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-0529-0_6</ArticleId><ArticleId IdType="pubmed">29951816</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson MR, Lagow RD, Xu K, Zhang B, Bonini NM. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem. 2008;283(36):24972&#x2013;24981. doi: 10.1074/jbc.M804817200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804817200</ArticleId><ArticleId IdType="pmc">PMC2529125</ArticleId><ArticleId IdType="pubmed">18596033</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia AJ, Parkes TL, Kirby K, St George-Hyslop P, Boulianne GL, Phillips JP, et al. Expression of human FALS SOD in motorneurons of Drosophila. Free Radic Biol Med. 1999;26(9&#x2013;10):1332&#x2013;1338. doi: 10.1016/S0891-5849(98)00333-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(98)00333-5</ArticleId><ArticleId IdType="pubmed">10381207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahadorani S, Mukai ST, Rabie J, Beckman JS, Phillips JP, Hilliker AJ. Expression of zinc-deficient human superoxide dismutase in Drosophila neurons produces a locomotor defect linked to mitochondrial dysfunction. Neurobiol Aging. 2013;34(10):2322&#x2013;2330. doi: 10.1016/j.neurobiolaging.2013.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.03.024</ArticleId><ArticleId IdType="pmc">PMC4145400</ArticleId><ArticleId IdType="pubmed">23601674</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118(2):401&#x2013;415. doi: 10.1242/dev.118.2.401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.118.2.401</ArticleId><ArticleId IdType="pubmed">8223268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin A, Held A, Bredvik K, Major P, Achilli TM, Kerson AG, et al. Human SOD1 ALS mutations in a drosophila knock-in model cause severe phenotypes and reveal dosage-sensitive gain- and loss-of-function components. Genetics. 2017;205(2):707&#x2013;723. doi: 10.1534/genetics.116.190850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.116.190850</ArticleId><ArticleId IdType="pmc">PMC5289846</ArticleId><ArticleId IdType="pubmed">27974499</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Yang M, Deng J, Chen X, Ye Y, Zhu L, et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell. 2011;2(6):477&#x2013;486. doi: 10.1007/s13238-011-1065-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1065-7</ArticleId><ArticleId IdType="pmc">PMC3563268</ArticleId><ArticleId IdType="pubmed">21748598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasayama H, Shimamura M, Tokuda T, Azuma Y, Yoshida T, Mizuno T, et al. Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches. PLoS ONE. 2012;7(6):e39483. doi: 10.1371/journal.pone.0039483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039483</ArticleId><ArticleId IdType="pmc">PMC3378546</ArticleId><ArticleId IdType="pubmed">22724023</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin KR, Godena VK, Hewitt VL, Whitworth AJ. Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum Mol Genet. 2016;25(12):2378&#x2013;2392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson NA, Jr, Maltare A, King H, Smith R, Kim JH, Taylor JP, et al. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum Mol Genet. 2011;20(13):2510&#x2013;2523. doi: 10.1093/hmg/ddr150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr150</ArticleId><ArticleId IdType="pmc">PMC4288133</ArticleId><ArticleId IdType="pubmed">21487023</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JW, Brent JR, Tomlinson A, Shneider NA, McCabe BD. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J Clin Investig. 2011;121(10):4118&#x2013;4126. doi: 10.1172/JCI57883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57883</ArticleId><ArticleId IdType="pmc">PMC3195475</ArticleId><ArticleId IdType="pubmed">21881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert J, Scheveneels W, Vanneste J, Van Damme P, Robberecht W, Callaerts P, et al. FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum Mol Genet. 2018;27(23):4103&#x2013;4116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240733</ArticleId><ArticleId IdType="pubmed">30379317</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Khalil B, Smith CL, Rossoll W. Traffic jam at the nuclear pore: all roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol Dis. 2020;140:104835. doi: 10.1016/j.nbd.2020.104835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104835</ArticleId><ArticleId IdType="pmc">PMC7253339</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallik M, Catinozzi M, Hug CB, Zhang L, Wagner M, Bussmann J, et al. Xrp1 genetically interacts with the ALS-associated FUS orthologue caz and mediates its toxicity. J Cell Biol. 2018;217(11):3947&#x2013;3964. doi: 10.1083/jcb.201802151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201802151</ArticleId><ArticleId IdType="pmc">PMC6219715</ArticleId><ArticleId IdType="pubmed">30209068</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakisaka KT, Tanaka R, Hirashima T, Muraoka Y, Azuma Y, Yoshida H, et al. Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disorders. Brain Res. 2019;1708:207&#x2013;219. doi: 10.1016/j.brainres.2018.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.028</ArticleId><ArticleId IdType="pubmed">30578769</ArticleId></ArticleIdList></Reference><Reference><Citation>Casci I, Krishnamurthy K, Kour S, Tripathy V, Ramesh N, Anderson EN, et al. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization. Nat Commun. 2019;10(1):5583. doi: 10.1038/s41467-019-13383-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13383-z</ArticleId><ArticleId IdType="pmc">PMC6898697</ArticleId><ArticleId IdType="pubmed">31811140</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y, Tokuda T, Kushimura Y, Yamamoto I, Mizuta I, Mizuno T, et al. Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Exp Cell Res. 2018;371(2):311&#x2013;321. doi: 10.1016/j.yexcr.2018.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.08.001</ArticleId><ArticleId IdType="pubmed">30092221</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogia N, Sarkar A, Mehta AS, Ramesh N, Deshpande P, Kango-Singh M, et al. Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo. Neurobiol Dis. 2020;140:104837. doi: 10.1016/j.nbd.2020.104837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104837</ArticleId><ArticleId IdType="pmc">PMC9277911</ArticleId><ArticleId IdType="pubmed">32199908</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS, Boehringer A, Zwick R, Tang JE, Grigsby B, Zarnescu DC. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet. 2011;20(12):2308&#x2013;2321. doi: 10.1093/hmg/ddr124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr124</ArticleId><ArticleId IdType="pmc">PMC3098735</ArticleId><ArticleId IdType="pubmed">21441568</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ray P, Rao EJ, Shi C, Guo W, Chen X, et al. A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci USA. 2010;107(7):3169&#x2013;3174. doi: 10.1073/pnas.0913602107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913602107</ArticleId><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin MJ, Cheng CW, Shen CK. Neuronal function and dysfunction of Drosophila dTDP. PLoS ONE. 2011;6(6):e20371. doi: 10.1371/journal.pone.0020371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020371</ArticleId><ArticleId IdType="pmc">PMC3105987</ArticleId><ArticleId IdType="pubmed">21673800</ArticleId></ArticleIdList></Reference><Reference><Citation>Langellotti S, Romano V, Romano G, Klima R, Feiguin F, Cragnaz L, et al. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects. Dis Model Mech. 2016;9(6):659&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4920146</ArticleId><ArticleId IdType="pubmed">27101846</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F, Godena VK, Romano G, D'Ambrogio A, Klima R, Baralle FE. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009;583(10):1586&#x2013;1592. doi: 10.1016/j.febslet.2009.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pubmed">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron. 2017;93(5):1015&#x2013;1034. doi: 10.1016/j.neuron.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.01.022</ArticleId><ArticleId IdType="pubmed">28279350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Duan Y, Qin C, Li JC, Duan G, Deng X, et al. Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis. 2018;9(10):953. doi: 10.1038/s41419-018-1022-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1022-y</ArticleId><ArticleId IdType="pmc">PMC6148241</ArticleId><ArticleId IdType="pubmed">30237395</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B, Cabirol-Pol MJ, Miguel L, Whitworth AJ, Lecourtois M, Lievens JC. Enhancing mitofusin/marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies. Neurobiol Aging. 2017;54:71&#x2013;83. doi: 10.1016/j.neurobiolaging.2017.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.02.016</ArticleId><ArticleId IdType="pubmed">28324764</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E, Lorenzini I, Barrameda D, O'Conner AG, Barrows JM, Starr A, et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. Elife. 2019;8:e45114. doi: 10.7554/eLife.45114.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45114</ArticleId><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Siddegowda BB, Estes PS, Johannesmeyer J, Kovalik T, Daniel SG, et al. Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J Neurosci. 2014;34(48):15962&#x2013;15974. doi: 10.1523/JNEUROSCI.2526-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2526-14.2014</ArticleId><ArticleId IdType="pmc">PMC4244467</ArticleId><ArticleId IdType="pubmed">25429138</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, Du A, Gu J, Duan G, Wang C, Gui X, et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res. 2019;29(3):233&#x2013;247. doi: 10.1038/s41422-019-0141-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0141-z</ArticleId><ArticleId IdType="pmc">PMC6460439</ArticleId><ArticleId IdType="pubmed">30728452</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee KH, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525(7567):129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gronke S, Niccoli T, Ridler CE, Clayton EL, Devoy A, et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345(6201):1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Prudencio M, Kramer NJ, Martinez-Ramirez LF, Srinivasan AR, Lan M, et al. Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. Nat Neurosci. 2019;22(6):863&#x2013;874. doi: 10.1038/s41593-019-0396-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0396-1</ArticleId><ArticleId IdType="pmc">PMC6535128</ArticleId><ArticleId IdType="pubmed">31110321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, Carlomagno Y, Zhang YJ, Almeida S, Cook CN, Gendron TF, et al. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science. 2016;353(6300):708&#x2013;712. doi: 10.1126/science.aaf7791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf7791</ArticleId><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Bonini NM. New roles for canonical transcription factors in repeat expansion diseases. Trends Genet. 2020;36(2):81&#x2013;92. doi: 10.1016/j.tig.2019.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2019.11.003</ArticleId><ArticleId IdType="pmc">PMC6980727</ArticleId><ArticleId IdType="pubmed">31837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525(7567):56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham KM, Maulding K, Ruan K, Senturk M, Grima JC, Sung H, et al. TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS. Elife. 2020;9:e59419. doi: 10.7554/eLife.59419.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59419</ArticleId><ArticleId IdType="pmc">PMC7758070</ArticleId><ArticleId IdType="pubmed">33300868</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Prudencio M, Srinivasan AR, Rifai OM, Lee VM, Petrucelli L, et al. eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS. Acta Neuropathol Commun. 2019;7(1):62. doi: 10.1186/s40478-019-0711-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0711-9</ArticleId><ArticleId IdType="pmc">PMC6485101</ArticleId><ArticleId IdType="pubmed">31023341</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay-Ginsburg S, Di Salvio M, Weitman M, Afri M, Ribeiro S, Ebbinghaus S, et al. Chemical chaperones targeted to the endoplasmic reticulum (ER) and lysosome prevented neurodegeneration in a C9orf72 repeat expansion drosophila amyotrophic lateral sclerosis (ALS) model. Pharmacol Rep. 2021;73(2):536&#x2013;550. doi: 10.1007/s43440-021-00226-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-021-00226-2</ArticleId><ArticleId IdType="pubmed">33661518</ArticleId></ArticleIdList></Reference><Reference><Citation>Canto MD, Gurney ME. A low expressor line of transgenic mice carrying a mutant human Cu, Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta neuropathol. 1997;93:537&#x2013;550. doi: 10.1007/s004010050650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050650</ArticleId><ArticleId IdType="pubmed">9194892</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarta E, Bravi R, Scambi I, Mariotti R, Minciacchi D. Increased anxiety-like behavior and selective learning impairments are concomitant to loss of hippocampal interneurons in the presymptomatic SOD1 (G93A) ALS mouse model. J Comp Neurol. 2015;523(11):1622&#x2013;1638. doi: 10.1002/cne.23759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23759</ArticleId><ArticleId IdType="pubmed">25684566</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafuri F, Ronchi D, Magri F, Comi GP, Corti S. SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis. Front Cell Neurosci. 2015;9:336. doi: 10.3389/fncel.2015.00336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00336</ArticleId><ArticleId IdType="pmc">PMC4548205</ArticleId><ArticleId IdType="pubmed">26379505</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-C, Chiang P-M, Tsai K-J. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Int J Mol Sci. 2013;14(10):20079&#x2013;20111. doi: 10.3390/ijms141020079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms141020079</ArticleId><ArticleId IdType="pmc">PMC3821604</ArticleId><ArticleId IdType="pubmed">24113586</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci USA. 2008;105(10):4022&#x2013;4027. doi: 10.1073/pnas.0712209105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Velde CV, Ward CM, Miller TM, et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43(1):5&#x2013;17. doi: 10.1016/j.neuron.2004.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Takikawa M, Nakashima K, Hirano A, Cleveland DW, Kusaka H, et al. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes. Amyotroph Later Scler Frontotempor Degener. 2000;1(3):163&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464950</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D, Haasdijk ED, Grashorn J, Hawkins R, van Duijn W, Verspaget HW, et al. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol Dis. 2000;7(6):623&#x2013;643. doi: 10.1006/nbdi.2000.0299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0299</ArticleId><ArticleId IdType="pubmed">11114261</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Bareil C, Robertson J, Rouleau GA, Kriz J, et al. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain. 2011;134(9):2610&#x2013;2626. doi: 10.1093/brain/awr159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr159</ArticleId><ArticleId IdType="pubmed">21752789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA. 2009;106(44):18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Arakawa H, Wang L, Okolo O, Siedlak SL, Jiang Y, et al. Motor-coordinative and cognitive dysfunction caused by mutant TDP-43 could be reversed by inhibiting its mitochondrial localization. Mol Ther. 2017;25(1):127&#x2013;139. doi: 10.1016/j.ymthe.2016.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2016.10.013</ArticleId><ArticleId IdType="pmc">PMC5363201</ArticleId><ArticleId IdType="pubmed">28129109</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssens J, Wils H, Kleinberger G, Joris G, Cuijt I, Ceuterick-de Groote C, et al. Overexpression of ALS-associated p. M337V human TDP-43 in mice worsens disease features compared to wild-type human TDP-43 mice. Mol Neurobiol. 2013;48:22&#x2013;35. doi: 10.1007/s12035-013-8427-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8427-5</ArticleId><ArticleId IdType="pmc">PMC3718993</ArticleId><ArticleId IdType="pubmed">23475610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditsworth D, Maldonado M, McAlonis-Downes M, Sun S, Seelman A, Drenner K, et al. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:907&#x2013;922. doi: 10.1007/s00401-017-1698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1698-6</ArticleId><ArticleId IdType="pmc">PMC5427168</ArticleId><ArticleId IdType="pubmed">28357566</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling S-C, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci USA. 2013;110(8):E736&#x2013;E745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA. 2010;107(8):3858&#x2013;3863. doi: 10.1073/pnas.0912417107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912417107</ArticleId><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Valdmanis P, Millecamps S, Lionnet C, Blasco H, Mouzat K, et al. Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations. Neurology. 2012;78(19):1519&#x2013;1526. doi: 10.1212/WNL.0b013e3182553c88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182553c88</ArticleId><ArticleId IdType="pubmed">22539580</ArticleId></ArticleIdList></Reference><Reference><Citation>Efimova A, Ovchinnikov R, Roman AY, Maltsev A, Grigoriev V, Kovrazhkina E, et al. The FUS protein: physiological functions and a role in amyotrophic lateral sclerosis. Mol Biol. 2017;51:341&#x2013;351. doi: 10.1134/S0026893317020091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0026893317020091</ArticleId><ArticleId IdType="pubmed">28707655</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Danel V, Lacour A, Beltran S, Andres C, Couratier P, et al. A novel mutation of the C-terminal amino acid of FUS (Y526C) strengthens FUS gene as the most frequent genetic factor in aggressive juvenile ALS. Amyotroph Later Scler Frontotempor Degener. 2017;18(3&#x2013;4):298&#x2013;301. doi: 10.1080/21678421.2016.1265564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1265564</ArticleId><ArticleId IdType="pubmed">28054830</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Talbot K, Ansorge O. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathol Commun. 2016;4(1):99. doi: 10.1186/s40478-016-0358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0358-8</ArticleId><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, McGoldrick P, Vance C, Hortobagyi T, Sreedharan J, Rogelj B, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age-and dose-dependent fashion. Acta Neuropathol. 2013;125(2):273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Oussini HE, Mersmann S, Drenner K, Wagner M, Sun Y, et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Sanjuan-Ruiz I, Kan V, Megat S, De Rossi P, Dieterl&#xe9; S, et al. Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects. Nat Commun. 2021;12(1):3028. doi: 10.1038/s41467-021-23187-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23187-9</ArticleId><ArticleId IdType="pmc">PMC8140148</ArticleId><ArticleId IdType="pubmed">34021132</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Sendscheid O, El Oussini H, Jambeau M, Sun Y, Mersmann S, et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35(10):1077&#x2013;1097. doi: 10.15252/embj.201592559.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592559</ArticleId><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanovsky-Dagan S, Mor-Shaked H, Eiges R. Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells. World J Stem Cells. 2015;7(5):823. doi: 10.4252/wjsc.v7.i5.823.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v7.i5.823</ArticleId><ArticleId IdType="pmc">PMC4478629</ArticleId><ArticleId IdType="pubmed">26131313</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, Bogdanik L, Muhammad A, Gendron TF, Kim KJ, Austin A, et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron. 2015;88(5):892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Gendron TF, Prudencio M, Sasaguri H, Zhang Y-J, Castanedes-Casey M, et al. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348(6239):1151&#x2013;1154. doi: 10.1126/science.aaa9344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM, et al. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol Neurodegener. 2019;14:1&#x2013;15. doi: 10.1186/s13024-019-0310-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Herranz-Martin S, Chandran J, Lewis K, Mulcahy P, Higginbottom A, Walker C, et al. Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits. Dis Model Mech. 2017;10(7):859&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536911</ArticleId><ArticleId IdType="pubmed">28550099</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90(3):521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L, Beal M, Becher M, Schulz J, Wong P, Price D, et al. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA. 1997;94(14):7606&#x2013;7611. doi: 10.1073/pnas.94.14.7606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.14.7606</ArticleId><ArticleId IdType="pmc">PMC23869</ArticleId><ArticleId IdType="pubmed">9207139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14(6):1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Gama Sosa MA, De Gasperi R, Elder GA. Modeling human neurodegenerative diseases in transgenic systems. Hum Genet. 2012;131(4):535&#x2013;563. doi: 10.1007/s00439-011-1119-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-011-1119-1</ArticleId><ArticleId IdType="pubmed">22167414</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7(6):557&#x2013;570. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bame M, Pentiak PA, Needleman R, Brusilow WS. Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1 G93A mouse model for ALS. Gend Med. 2012;9(6):524&#x2013;535. doi: 10.1016/j.genm.2012.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2012.10.014</ArticleId><ArticleId IdType="pubmed">23217569</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133(6):863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce PI, Mcgoldrick P, Saccon RA, Weber W, Fratta P, West SJ, et al. A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity. Hum Mol Genet. 2015;24(7):1883&#x2013;1897. doi: 10.1093/hmg/ddu605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu605</ArticleId><ArticleId IdType="pmc">PMC4355022</ArticleId><ArticleId IdType="pubmed">25468678</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Graffmo KS, Br&#xe4;nnstr&#xf6;m T, Nilsson P, Andersen PM, Marklund SL. Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. J Neuropathol Exp Neurol. 2006;65(12):1126&#x2013;1136. doi: 10.1097/01.jnen.0000248545.36046.3c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248545.36046.3c</ArticleId><ArticleId IdType="pubmed">17146286</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Rothstein JD. Rodent models of amyotrophic lateral sclerosis. Curr Protoc Pharmacol. 2015;69:56721&#x2013;656761. doi: 10.1002/0471141755.ph0567s69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471141755.ph0567s69</ArticleId><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007;6(12):1045&#x2013;1053. doi: 10.1016/S1474-4422(07)70270-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70270-3</ArticleId><ArticleId IdType="pubmed">17980667</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc Natl Acad Sci USA. 2002;99(3):1604&#x2013;1609. doi: 10.1073/pnas.032539299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.032539299</ArticleId><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanagi T, Yuasa S, Nakamura Y, Suzuki E, Aoki M, Warita H, et al. Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis. J Neurosci Res. 2010;88(12):2736&#x2013;2746.</Citation><ArticleIdList><ArticleId IdType="pubmed">20648658</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, et al. Rats expressing human cytosolic copper&#x2013;zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci. 2001;21(23):9246&#x2013;9254. doi: 10.1523/JNEUROSCI.21-23-09246.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-23-09246.2001</ArticleId><ArticleId IdType="pmc">PMC6763929</ArticleId><ArticleId IdType="pubmed">11717358</ArticleId></ArticleIdList></Reference><Reference><Citation>Magota H, Sasaki M, Kataoka-Sasaki Y, Oka S, Ukai R, Kiyose R, et al. Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model. Brain Res. 2021;1757:147296. doi: 10.1016/j.brainres.2021.147296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2021.147296</ArticleId><ArticleId IdType="pubmed">33516815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz C. Mouse models of ALS: past, present and future. Brain Res. 2018;1693(Pt A):1&#x2013;10. doi: 10.1016/j.brainres.2018.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.03.024</ArticleId><ArticleId IdType="pubmed">29577886</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci. 2010;30(32):10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu YF, Zhang YJ, Lin WL, Cao X, Stetler C, Dickson DW, et al. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Mol Neurodegener. 2011;6:73. doi: 10.1186/1750-1326-6-73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-73</ArticleId><ArticleId IdType="pmc">PMC3216869</ArticleId><ArticleId IdType="pubmed">22029574</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfieri JA, Silva PR, Igaz LM. Early cognitive/social deficits and late motor phenotype in conditional wild-type TDP-43 transgenic mice. Front Aging Neurosci. 2016;8:310. doi: 10.3389/fnagi.2016.00310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00310</ArticleId><ArticleId IdType="pmc">PMC5167738</ArticleId><ArticleId IdType="pubmed">28066234</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu LS, Cheng WC, Hou SC, Yan YT, Jiang ST, Shen CKJ. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis. 2010;48(1):56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">20014337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin AS, Lee VM, Trojanowski JQ. TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol. 2010;6(4):211&#x2013;220. doi: 10.1038/nrneurol.2010.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.18</ArticleId><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X, Chiang PM, Price DL, Wong PC. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci USA. 2010;107(37):16325&#x2013;16330. doi: 10.1073/pnas.1003459107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1003459107</ArticleId><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, Constable R, So E, Vance C, Scotter E, Glover L, et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol Commun. 2015;3:36. doi: 10.1186/s40478-015-0212-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0212-4</ArticleId><ArticleId IdType="pmc">PMC4479086</ArticleId><ArticleId IdType="pubmed">26108367</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Tong J, Bi F, Zhou H, Xia XG. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats. J Clin Investig. 2012;122(1):107&#x2013;118. doi: 10.1172/JCI59130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI59130</ArticleId><ArticleId IdType="pmc">PMC3248298</ArticleId><ArticleId IdType="pubmed">22156203</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S, Wang CE, Wei W, Gaertig MA, Lai L, Li S, et al. TDP-43 causes differential pathology in neuronal versus glial cells in the mouse brain. Hum Mol Genet. 2014;23(10):2678&#x2013;2693. doi: 10.1093/hmg/ddt662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt662</ArticleId><ArticleId IdType="pmc">PMC3990167</ArticleId><ArticleId IdType="pubmed">24381309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Huang C, Chen H, Wang D, Landel CP, Xia PY, et al. Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet. 2010;6(3):e1000887. doi: 10.1371/journal.pgen.1000887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000887</ArticleId><ArticleId IdType="pmc">PMC2845661</ArticleId><ArticleId IdType="pubmed">20361056</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ, Tsai PY, Chern Y. Energy homeostasis and abnormal RNA metabolism in amyotrophic lateral sclerosis. Front Cell Neurosci. 2017;11:126. doi: 10.3389/fncel.2017.00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00126</ArticleId><ArticleId IdType="pmc">PMC5415567</ArticleId><ArticleId IdType="pubmed">28522961</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323(5918):1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H, Lee S, Shang Y, Wang W-Y, Au KF, Kamiya S, et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Investig. 2014;124(3):981&#x2013;999. doi: 10.1172/JCI72723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72723</ArticleId><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Gois AM, Mendonca DMF, Freire MAM, Santos JR. In vitro and in vivo models of amyotrophic lateral sclerosis: an updated overview. Brain Res Bull. 2020;159:32&#x2013;43. doi: 10.1016/j.brainresbull.2020.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2020.03.012</ArticleId><ArticleId IdType="pubmed">32247802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Dastidar SG, Tokunaga S, Ho WY, Lim K, Ilieva H, et al. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. Elife. 2019;8:e40811. doi: 10.7554/eLife.40811.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.40811</ArticleId><ArticleId IdType="pmc">PMC6389288</ArticleId><ArticleId IdType="pubmed">30747709</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson KL, Dhaibar HA, Dayton RD, Cananzi SG, Mayhan WG, Glasscock E, et al. Severe respiratory changes at end stage in a FUS-induced disease state in adult rats. BMC Neurosci. 2016;17(1):1&#x2013;11. doi: 10.1186/s12868-016-0304-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12868-016-0304-5</ArticleId><ArticleId IdType="pmc">PMC5086065</ArticleId><ArticleId IdType="pubmed">27793099</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Poidevin M, Li X, Li Y, Shu L, Nelson DL, et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci USA. 2013;110(19):7778&#x2013;7783. doi: 10.1073/pnas.1219643110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, et al. Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron. 2016;90(3):535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Cabrera GT, Tran H, Gendron TF, McKeon JE, Metterville J, et al. Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice. Neuron. 2015;88(5):902&#x2013;909. doi: 10.1016/j.neuron.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra R, Lee CW. Mouse models of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis/frontotemporal dementia. Front Cell Neurosci. 2017;11:196. doi: 10.3389/fncel.2017.00196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00196</ArticleId><ArticleId IdType="pmc">PMC5498553</ArticleId><ArticleId IdType="pubmed">28729824</ArticleId></ArticleIdList></Reference><Reference><Citation>Mordes DA, Morrison BM, Ament XH, Cantrell C, Mok J, Eggan P, et al. Absence of survival and motor deficits in 500 repeat C9ORF72 BAC mice. Neuron. 2020;108(4):775&#x2013;783. doi: 10.1016/j.neuron.2020.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.009</ArticleId><ArticleId IdType="pubmed">33022228</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci. 2020;23(5):615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, Li Y, Chang W-H, Hung S-T, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24(3):313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, Blokhuis AM, Westeneng HJ, Terpstra ML, Zundel CA, Vieira de S&#xe1; R, et al. C 9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann Neurol. 2015;78(3):426&#x2013;438. doi: 10.1002/ana.24453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W, Ma Y, Guan F, Zhang X, Chen W, Zhang L, et al. Ablation of C9orf72 together with excitotoxicity induces ALS in rats. FEBS J. 2021;288(5):1712&#x2013;1723. doi: 10.1111/febs.15501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15501</ArticleId><ArticleId IdType="pubmed">32745320</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W, Zhang L, Sun C, Gao X, Guan F, Li J, et al. Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats. Animal Model Exp Med. 2020;3(3):237&#x2013;244. doi: 10.1002/ame2.12129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ame2.12129</ArticleId><ArticleId IdType="pmc">PMC7529333</ArticleId><ArticleId IdType="pubmed">33024945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghbi HY, Botas J. Mouse and fly models of neurodegeneration. Trends Genet. 2002;18(9):463&#x2013;471. doi: 10.1016/S0168-9525(02)02729-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-9525(02)02729-4</ArticleId><ArticleId IdType="pubmed">12175807</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332&#x2013;1340. doi: 10.1038/s41593-018-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook ZR, Housman D. Huntington's disease: Can mice lead the way to treatment? Neuron. 2011;69(3):423&#x2013;435. doi: 10.1016/j.neuron.2010.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.12.035</ArticleId><ArticleId IdType="pmc">PMC4685469</ArticleId><ArticleId IdType="pubmed">21315254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada T, Tong Y, Gautier CA, Shen J. Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice. J Neurochem. 2009;111(3):696&#x2013;702. doi: 10.1111/j.1471-4159.2009.06350.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06350.x</ArticleId><ArticleId IdType="pmc">PMC2952933</ArticleId><ArticleId IdType="pubmed">19694908</ArticleId></ArticleIdList></Reference><Reference><Citation>Averill DR., Jr Degenerative myelopathy in the aging German Shepherd dog: clinical and pathologic findings. J Am Vet Med Assoc. 1973;162(12):1045&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">4196853</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R, Holler Y, Taylor AC, Lochner P, Tezzon F, Golaszewski S, et al. Canine degenerative myelopathy: a model of human amyotrophic lateral sclerosis. Zoology (Jena) 2016;119(1):64&#x2013;73. doi: 10.1016/j.zool.2015.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.zool.2015.09.003</ArticleId><ArticleId IdType="pubmed">26432396</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel WK, Kurland LT, Klatzo I. An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement. An intermediate form? Brain. 1959;82:203&#x2013;220. doi: 10.1093/brain/82.2.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/82.2.203</ArticleId><ArticleId IdType="pubmed">13849712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol. 1967;16(3):232&#x2013;243. doi: 10.1001/archneur.1967.00470210008002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1967.00470210008002</ArticleId><ArticleId IdType="pubmed">6018874</ArticleId></ArticleIdList></Reference><Reference><Citation>Awano T, Johnson GS, Wade CM, Katz ML, Johnson GC, Taylor JF, et al. Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2009;106(8):2794&#x2013;2799. doi: 10.1073/pnas.0812297106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812297106</ArticleId><ArticleId IdType="pmc">PMC2634802</ArticleId><ArticleId IdType="pubmed">19188595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wininger FA, Zeng R, Johnson GS, Katz ML, Johnson GC, Bush WW, et al. Degenerative myelopathy in a Bernese Mountain Dog with a novel SOD1 missense mutation. J Vet Intern Med. 2011;25(5):1166&#x2013;1170. doi: 10.1111/j.1939-1676.2011.0760.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1939-1676.2011.0760.x</ArticleId><ArticleId IdType="pubmed">21848967</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp MJ, Beckett J, Coates JR, Miller TM. Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model. Exp Neurol. 2013;248:1&#x2013;9. doi: 10.1016/j.expneurol.2013.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.05.009</ArticleId><ArticleId IdType="pmc">PMC3773294</ArticleId><ArticleId IdType="pubmed">23707216</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubczyk D, Malysz-Cymborska I, Kalkowski L, Janowski M, Coates JR, Wojtkiewicz J, et al. The role of glia in canine degenerative myelopathy: relevance to human amyotrophic lateral sclerosis. Mol Neurobiol. 2019;56(8):5740&#x2013;5748. doi: 10.1007/s12035-019-1488-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1488-3</ArticleId><ArticleId IdType="pmc">PMC6614142</ArticleId><ArticleId IdType="pubmed">30674036</ArticleId></ArticleIdList></Reference><Reference><Citation>Toedebusch CM, Snyder JC, Jones MR, Garcia VB, Johnson GC, Villalon EL, et al. Arginase-1 expressing microglia in close proximity to motor neurons were increased early in disease progression in canine degenerative myelopathy, a model of amyotrophic lateral sclerosis. Mol Cell Neurosci. 2018;88:148&#x2013;157. doi: 10.1016/j.mcn.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.01.009</ArticleId><ArticleId IdType="pubmed">29408267</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Trapero M, Espejo-Porras F, Rodriguez-Cueto C, Coates JR, Perez-Diaz C, de Lago E, et al. Upregulation of CB(2) receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis. Dis Model Mech. 2017;10(5):551&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451172</ArticleId><ArticleId IdType="pubmed">28069688</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendixen E, Danielsen M, Larsen K, Bendixen C. Advances in porcine genomics and proteomics&#x2013;a toolbox for developing the pig as a model organism for molecular biomedical research. Brief Funct Genom. 2010;9(3):208&#x2013;219. doi: 10.1093/bfgp/elq004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/elq004</ArticleId><ArticleId IdType="pubmed">20495211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind NM, Moustgaard A, Jelsing J, Vajta G, Cumming P, Hansen AK. The use of pigs in neuroscience: modeling brain disorders. Neurosci Biobehav Rev. 2007;31(5):728&#x2013;751. doi: 10.1016/j.neubiorev.2007.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2007.02.003</ArticleId><ArticleId IdType="pubmed">17445892</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjarkam CR, Nielsen MS, Glud AN, Rosendal F, Mogensen P, Bender D, et al. Neuromodulation in a minipig MPTP model of Parkinson disease. Br J Neurosurg. 2008;22(Suppl 1):S9&#x2013;12. doi: 10.1080/02688690802448285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02688690802448285</ArticleId><ArticleId IdType="pubmed">19085346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragh PM, Nielsen AL, Li J, Du Y, Lin L, Schmidt M, et al. Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw. Transgenic Res. 2009;18(4):545&#x2013;558. doi: 10.1007/s11248-009-9245-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11248-009-9245-4</ArticleId><ArticleId IdType="pubmed">19184503</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida M, Shimatsu Y, Onoe K, Matsuyama N, Niki R, Ikeda JE, et al. Production of transgenic miniature pigs by pronuclear microinjection. Transgenic Res. 2001;10(6):577&#x2013;582. doi: 10.1023/A:1013059917280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1013059917280</ArticleId><ArticleId IdType="pubmed">11817545</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm IE, Alstrup AK, Luo Y. Genetically modified pig models for neurodegenerative disorders. J Pathol. 2016;238(2):267&#x2013;287. doi: 10.1002/path.4654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4654</ArticleId><ArticleId IdType="pubmed">26446984</ArticleId></ArticleIdList></Reference><Reference><Citation>Chieppa MN, Perota A, Corona C, Grindatto A, Lagutina I, Vallino Costassa E, et al. Modeling amyotrophic lateral sclerosis in hSOD1 transgenic swine. Neurodegener Dis. 2014;13(4):246&#x2013;254. doi: 10.1159/000353472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000353472</ArticleId><ArticleId IdType="pubmed">24157939</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Wang G, Sun H, Shu R, Liu T, Wang CE, et al. Species-dependent neuropathology in transgenic SOD1 pigs. Cell Res. 2014;24(4):464&#x2013;481. doi: 10.1038/cr.2014.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2014.25</ArticleId><ArticleId IdType="pmc">PMC3975503</ArticleId><ArticleId IdType="pubmed">24577199</ArticleId></ArticleIdList></Reference><Reference><Citation>Crociara P, Chieppa MN, Vallino Costassa E, Berrone E, Gallo M, Lo Faro M, et al. Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALS. Neurobiol Dis. 2019;124:263&#x2013;275. doi: 10.1016/j.nbd.2018.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.11.021</ArticleId><ArticleId IdType="pubmed">30471417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Yang H, Yan S, Wang CE, Liu X, Zhao B, et al. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain. Mol Neurodegener. 2015;10:42. doi: 10.1186/s13024-015-0036-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0036-5</ArticleId><ArticleId IdType="pmc">PMC4557629</ArticleId><ArticleId IdType="pubmed">26334913</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolezalova D, Hruska-Plochan M, Bjarkam CR, Sorensen JC, Cunningham M, Weingarten D, et al. Pig models of neurodegenerative disorders: utilization in cell replacement-based preclinical safety and efficacy studies. J Comp Neurol. 2014;522(12):2784&#x2013;2801. doi: 10.1002/cne.23575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23575</ArticleId><ArticleId IdType="pubmed">24610493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Hernandez M, Tadokoro T, Navarro MR, Platoshyn O, Kobayashi Y, Marsala S, et al. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat Med. 2020;26(1):118&#x2013;130. doi: 10.1038/s41591-019-0674-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0674-1</ArticleId><ArticleId IdType="pmc">PMC8171115</ArticleId><ArticleId IdType="pubmed">31873312</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdier JM, Acquatella I, Lautier C, Devau G, Trouche S, Lasbleiz C, et al. Lessons from the analysis of nonhuman primates for understanding human aging and neurodegenerative diseases. Front Neurosci. 2015;9:64. doi: 10.3389/fnins.2015.00064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00064</ArticleId><ArticleId IdType="pmc">PMC4349082</ArticleId><ArticleId IdType="pubmed">25788873</ArticleId></ArticleIdList></Reference><Reference><Citation>Herculano-Houzel S, Mota B, Wong P, Kaas JH. Connectivity-driven white matter scaling and folding in primate cerebral cortex. Proc Natl Acad Sci USA. 2010;107(44):19008&#x2013;19013. doi: 10.1073/pnas.1012590107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1012590107</ArticleId><ArticleId IdType="pmc">PMC2973896</ArticleId><ArticleId IdType="pubmed">20956290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Sousa AM, Gao T, Skarica M, Li M, Santpere G, et al. Spatiotemporal transcriptomic divergence across human and macaque brain development. Science. 2018;362(6420):eaat8077. doi: 10.1126/science.aat8077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat8077</ArticleId><ArticleId IdType="pmc">PMC6900982</ArticleId><ArticleId IdType="pubmed">30545855</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida A, Sasaguri H, Kimura N, Tajiri M, Ohkubo T, Ono F, et al. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain. 2012;135(Pt 3):833&#x2013;846. doi: 10.1093/brain/awr348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr348</ArticleId><ArticleId IdType="pmc">PMC3286326</ArticleId><ArticleId IdType="pubmed">22252998</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel F, Gernoux G, Cardozo B, Metterville JP, Toro Cabrera GC, Song L, et al. Therapeutic rAAVrh10 mediated SOD1 silencing in adult SOD1(G93A) mice and nonhuman primates. Hum Gene Ther. 2016;27(1):19&#x2013;31. doi: 10.1089/hum.2015.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2015.122</ArticleId><ArticleId IdType="pmc">PMC4741242</ArticleId><ArticleId IdType="pubmed">26710998</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel F, Gernoux G, Sun H, Stock R, Blackwood M, Brown RH, Jr, et al. Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques. Sci Transl Med. 2018;10(465):eaau6414. doi: 10.1126/scitranslmed.aau6414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aau6414</ArticleId><ArticleId IdType="pubmed">30381409</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo K, Ishigaki S, Masamizu Y, Fujioka Y, Watakabe A, Yamamori T, et al. Silencing of FUS in the common marmoset (Callithrix jacchus) brain via stereotaxic injection of an adeno-associated virus encoding shRNA. Neurosci Res. 2018;130:56&#x2013;64. doi: 10.1016/j.neures.2017.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.08.006</ArticleId><ArticleId IdType="pubmed">28842245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P, Guo X, Yang W, Yan S, Yang S, Zhao T, et al. Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains. Acta Neuropathol. 2019;137(6):919&#x2013;937. doi: 10.1007/s00401-019-01979-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01979-0</ArticleId><ArticleId IdType="pmc">PMC6531422</ArticleId><ArticleId IdType="pubmed">30810811</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P, Bai D, Deng F, Zhang C, Jia Q, Zhu L, et al. SQSTM1-mediated clearance of cytoplasmic mutant TARDBP/TDP-43 in the monkey brain. Autophagy. 2022;18(8):1955&#x2013;1968. doi: 10.1080/15548627.2021.2013653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.2013653</ArticleId><ArticleId IdType="pmc">PMC9466617</ArticleId><ArticleId IdType="pubmed">34936539</ArticleId></ArticleIdList></Reference><Reference><Citation>Modrek B, Lee CJ. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss. Nat Genet. 2003;34(2):177&#x2013;180. doi: 10.1038/ng1159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1159</ArticleId><ArticleId IdType="pubmed">12730695</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>